MEG3 can reduce the deposition of Aβ 25–35 and oxidative stress in the hippocampus of rats with AD, and reduce the inflammatory injury by downregulating IL-1 β, IL-6 and TNF- α. The gene discussed is IL6; the disease is Alzheimer disease.